ICD-10-CM Billable Code

F11.21

Opioid dependence, in remission

Clinical Classification Guidelines

Inclusion Terms

  • Opioid use disorder, moderate, in early remission
  • Opioid use disorder, moderate, in sustained remission
  • Opioid use disorder, severe, in early remission
  • Opioid use disorder, severe, in sustained remission

Medical Intelligence & Overview

ICD-10 code F11.21 refers to a condition where an individual previously experienced opioid dependence but is currently in remission. This status indicates that the person has successfully reduced or ceased their opioid use to a level that does not meet the criteria for active dependence. Remission can be classified as either early or sustained, depending on how long the individual has maintained their abstinence or controlled use. Recognizing this condition helps healthcare providers tailor ongoing support and treatment strategies to sustain recovery and address any underlying issues related to opioid use disorder.

Causes & Symptoms

Clinical Causes: Previous long-term opioid use leading to dependence Medical or psychological interventions aiding in cessation Lifestyle changes and support systems promoting sobriety Use of medication-assisted treatment (MAT), such as methadone or buprenorphine Psychological therapy and behavioral interventions Increased awareness and education about the risks of opioids

Key Symptoms: Absence of cravings for opioids No recent use of opioids over a sustained period Reduced or eliminated withdrawal symptoms Engagement in daily activities without opioid dependence Improved mental health and emotional stability Stable social and occupational functioning

Diagnostic & Treatment

Diagnosis Path: Diagnosis of opioid dependence in remission is typically made through clinical assessment, patient history, and adherence to criteria outlined in psychiatric diagnostic tools such as the DSM-5. Healthcare professionals evaluate the duration of abstinence, history of dependence severity, and the presence or absence of cravings and withdrawal symptoms. The distinction between early and sustained remission is based on the length of time since the last opioid use—generally, early remission is defined as absence of symptoms for more than 3 months but less than 12 months, while sustained remission exceeds 12 months.

Treatment Protocols: While the individual is currently in remission, ongoing management aims to maintain sobriety and address any underlying factors contributing to opioid dependence. Typical approaches include: - Continued participation in counseling or support groups - Medication-assisted treatment (if applicable) - Monitoring for signs of relapse - Addressing co-occurring mental health conditions - Psychoeducation to reinforce the importance of abstinence Engagement with healthcare providers remains crucial to prevent relapse and support long-term recovery.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F11.21 a billable ICD-10 code?
Yes, F11.21 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F11.21?
Clinical documentation must specify the nature of Opioid dependence, in remission and any associated comorbidities for accurate reporting.

Cite this Clinical Reference